THE COMPETITION COUNCIL APPEALED THE COURT'S DECISION REGARDING THE AGREEMENT BETWEEN PHARMACEUTICAL COMPANIES
The dispute over whether the Lithuanian Pharmaceutical Association (LPA) and its members were justifiably fined for entering into an anti-competitive agreement is moving to the Supreme Administrative Court of Lithuania – today, the Competition Council submitted an appeal outlining the reasons why it is requesting the annulment of the decision...
COMPETITION COUNCIL WILL CONSIDER APPEALING THE COURT‘S RULING ON THE PHARMACIES’ AGREEMENT
The Regional Administrative Court issued a ruling yesterday on the contested decision of the Competition Council, which had established that pharmaceuticals companies entered into an anti-competitive agreement between.
THE UNDERTAKINGS' ANTI-COMPETITIVE AGREEMENT DENIED CONSUMERS LOWER PRICES FOR FOOD SUPPLEMENTS AND COSMETICS
The Competition Council found that Giantera , the official representative of the Dr. Ohhira brand in Lithuania, and 19 distributors of its products had agreed not to sell food supplements and cosmetic products at prices lower than the supplier's prices, and not to offer discounts and promotions to consumers. The companies were fined a total...
The Lithuanian competition authority Konkurencijos taryba has found that the Lithuanian Pharmacy Association (LPA) and 8 pharmaceutical companies agreed on the margins of reimbursable medicines. The infringement of the Law on Competition and the Treaty on the Functioning of the European Union resulted in more than EUR 72 million in fines.
Konkurencijos taryba cleared the acquisition of joint control of UAB Taikos centras by the Latvian company New Bumani Invest and Raimundas Petrikas.
On February 24, 2017 the Competition Council terminated the investigation into the requirements for pharmacy premises and equipment approved by the Ministry of Health in 2003 (hereinafter – Requirements). The investigation was terminated after the Ministry of Health amended the Requirements to ensure equal competitive opportunities...
The Competition Council (hereinafter – Council) found that UAB Nemuno vaistinė (hereinafter – Company) made false claims about 30 per cent cheaper products sold in the pharmacies of Camelia (hereinafter – Camelia ), and thus breached Article 5 of the Law on Advertising.